Subject | Age | Type of CM | EF (%) | Delivery location | Arterial line | CVC | Delivery type | MACE event* |
1 | 18 | Other | 20 | Obstetric operating room | Yes | No | Caesarean section |
|
2 | 26 | Other | 30 | Obstetric operating room | Yes | Yes | Vaginal |
|
3 | 33 | Other | 30 | Heart hospital | Yes | Yes | Vaginal |
|
4 | 22 | Other | 20 | Heart hospital | Yes | No | Operative vaginal |
|
5 | 30 | PPCM | 30 | Heart hospital | Yes | No | Vaginal |
|
6 | 44 | PPCM | 35 | Heart hospital | Yes | Yes | Caesarean section |
|
*Referring to composite MACE events include: maternal death, inotrope use, LVAD, OHT or listingstatus change, acute decompensated heart failure or sustained ventricular arrhythmia up to 1-year post partum.
ADHF, acute decompensated heart failure; CM, cardiomyopathy; CVC, central venous catheter; DBA, dobutamine; EF, ejection fraction; LV, left ventricle; LVAD, left ventricular assist device; MACE, major adverse cardiovascular event; NICM, non-ischaemic cardiomyopathy; NSVT, non-sustained ventricular tachycardia; OHT, orthotopic heart transplant; PPCM, peripartum cardiomyopathy.